TGFB1 Kit CLIA

N° du produit ABIN6207975

Le kit ELISA TGFB1 (ABIN6207975) Cheval est un kit ELISA Chemiluminescent conçu pour quantifier Cheval TGFB1.

Aperçu rapide pour TGFB1 Kit CLIA (ABIN6207975)

Antigène: TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))

Reactivité: Cheval

Méthode de détection: Chemiluminescent

Type de méthode: Sandwich ELISA

Gamme de detection: 78 pg/mL - 5000 pg/mL

Application: ELISA

Type d'échantillon: Cell Culture Supernatant, Cell Lysate, Plasma, Platelet-Poor Plasma, Serum, Tissue Homogenate

Détail du produit TGFB1 Kit CLIA

Seuil minimal de détection: 78 pg/mL

Fonction: Horse Transforming Growth Factor beta 1 (TGFb1) CLIA Kit is a Sandwich CLIA Kit for use with Serum, platelet-poor plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Analytical Method: Quantitative

Sensibilité: < 28 pg/mL

Information d'application

Indications d'application:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plaque: Pre-coated

Restrictions: For Research Use only

Stockage

Stock: 4 °C/-20 °C

Stockage commentaire: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Date de péremption: 6 months

Détail du antigène

Antigène: TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))

Autre désignation: Transforming Growth Factor beta 1 (TGFb1)

Pathways: EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints